CompanyDrug

Seagen’s Adcetris Combo with Keytruda Shows Promising Results in Phase II Study

CompanyDrug

AstraZeneca Announces Positive Phase IIb Results for CKD Treatment Combination

DealsR&D

HKU and SIIDB Collaborate on Drug Development for Infectious Diseases

CompanyDrug

Dizal Pharmaceutical Presents Updates on DZD8586 and Golidocitinib at ASH Annual Meeting

CompanyDeals

XtalPi Inc. and CK Life Sciences Expand Partnership to Develop AI-Powered Cancer Diagnostics

CompanyDrug

Zhejiang Huahai Pharmaceutical’s HB0052 Receives US FDA IND Approval for Solid Tumors

CompanyDrug

BeiGene’s ZW25 on Track for Priority Review for Cholangiocarcinoma Treatment by CDE

CompanyDrug

Innovent Biologics Presents Positive Clinical Results for Efdamrofusp Alfa and IBI324 at AAO

CompanyDrug

CSPC Pharmaceutical Group Gets NMPA Approval for SYS6011 Biologic Drug Clinical Study

CompanyDeals

Bayer Extends Collaboration with Broad Institute to 2028 for Oncology Drug Targets and Therapies

CompanyDeals

AbbVie Secures Option Agreement with Aldeyra Therapeutics for RASP Modulator Reproxalap

Company

Novo Nordisk Reports 33% YOY Growth in Q3 2023 with Diabetes and Obesity Care Driving Sales